GTLS Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges Immunocore IMCR Q1 2026 Earnings Stunning EPS Beat Masks Caution as Shares Slide 39 SCLX Q1 2026 Earnings Net Loss of 476 per Share Stock Rises 321 VYGR Q1 2026 Earnings Adjusted Loss Narrower Than Expected Despite No Revenue Arcadia Biosciences RKDA Q3 2025 Profit Surges Past Wall Street Targets Lisata Therapeutics Q3 2025 Earnings NarrowerthanExpected Loss as Biotech Advances Clinical Pipeline